Skip to main content
    M

    MEDIFAST INC (MED)

    Official site

    CONSUMER CYCLICAL • PERSONAL SERVICES • NYSE

    $11.85
    +0.18 (+1.54%)

    Market Cap: $134.84M

    Last updated: Oct 16, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(33/39)
    Avg Surprise
    +29.04%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.35
    Range$-0.35 - $-0.35
    1 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.62+43.5%
    60d ago$-0.62+43.5%
    30d ago$-0.62+43.5%
    7d ago$-0.62+43.5%
    Current$-0.35
    Revenue Consensus
    $71M
    Range$71M - $71M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.37
    Range$0.37 - $0.37
    1 analysts
    Revenue Consensus
    $75M
    Range$75M - $75M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.37---
    Sep 26EST
    		-$-0.35---
    Jun 26
    Reported Aug 3
    		$-0.28N/A+58.21%Beat-227.3%
    Mar 26
    Reported May 4
    		$-0.19N/A+63.46%Beat-171.4%
    Dec 25
    Reported Feb 17
    		$-1.65$-0.45-266.67%Miss-1750.0%
    Sep 25
    Reported Nov 3
    		$-0.21$-0.36+41.67%Beat-160.0%
    Jun 25
    Reported Aug 4
    		$0.22$-0.19+215.79%Beat-76.1%
    Mar 25
    Reported Apr 28
    		$-0.07N/A+72.00%Beat-110.6%
    Dec 24
    Reported Feb 18
    		$0.10N/A-58.75%Miss-81.8%
    Sep 24
    Reported Nov 4
    		$0.35$-0.28+225.00%Beat-83.5%
    Jun 24
    Reported Aug 5
    		$0.92$0.39+135.90%Beat-66.8%
    Mar 24
    Reported Apr 29
    		$0.66$0.80-17.50%Miss-82.0%
    Dec 23
    Reported Feb 20
    		$0.55$0.96-42.71%Miss-83.2%
    Sep 23
    Reported Nov 6
    		$2.12$1.07+98.13%Beat-36.1%
    Jun 23
    Reported Aug 7
    		$2.77$1.44+92.36%Beat-28.4%
    Mar 23
    Reported May 1
    		$3.67$2.40+52.92%Beat+2.2%
    Dec 22
    Reported Feb 21
    		$3.27$2.22+47.30%Beat+12.4%
    Sep 22
    Reported Nov 3
    		$3.32$1.91+73.82%Beat-6.7%
    Jun 22
    Reported Aug 3
    		$3.87$3.23+19.81%Beat-2.3%
    Mar 22
    Reported May 2
    		$3.59$3.57+0.56%Beat+3.8%
    Dec 21
    Reported Feb 23
    		$2.91$2.65+9.81%Beat+23.3%
    Sep 21
    Reported Nov 4
    		$3.56$2.92+21.92%Beat+22.3%
    Jun 21
    Reported Aug 4
    		$3.96$3.30+20.00%Beat+102.0%
    Mar 21
    Reported May 4
    		$3.46$2.72+27.21%Beat+79.3%
    Dec 20
    Reported Feb 25
    		$2.36$2.38-0.84%Miss+42.2%
    Sep 20
    Reported Nov 2
    		$2.91$2.49+16.87%Beat+120.5%
    Jun 20
    Reported Aug 5
    		$1.96$1.84+6.52%Beat+12.0%
    Mar 20
    Reported May 5
    		$1.93$1.33+45.11%Beat+13.5%
    Dec 19
    Reported Feb 26
    		$1.66$1.08+53.70%Beat+27.7%
    Sep 19
    Reported Nov 7
    		$1.32$1.33-0.75%Miss+15.8%
    Jun 19
    Reported Aug 1
    		$1.75$1.72+1.74%Beat+50.9%
    Mar 19
    Reported May 1
    		$1.70$1.53+11.11%Beat+68.3%
    Dec 18
    Reported Feb 26
    		$1.30$1.21+7.44%Beat+116.7%
    Sep 18
    Reported Nov 6
    		$1.14$1.14+0.00%Beat+107.3%
    Jun 18
    Reported Aug 2
    		$1.16$0.98+18.37%Beat+84.1%
    Mar 18
    Reported May 3
    		$1.01$0.86+17.44%Beat+98.0%
    Dec 17
    Reported Mar 6
    		$0.60$0.48+25.00%Beat+76.5%
    Sep 17
    Reported Nov 7
    		$0.55$0.51+7.84%Beat-
    Jun 17
    Reported Aug 8
    		$0.63$0.52+21.15%Beat-
    Mar 17
    Reported May 4
    		$0.51$0.47+8.51%Beat-
    Dec 16
    Reported Mar 9
    		$0.34$0.33+3.03%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencyQuarterly

    Key Metrics

    Valuation
    P/E Ratio-5.09EV/EBITDAN/A
    Price/FCF32.88xFCF Yield3.04%
    Profitability
    Profit Margin-8.08%Operating Margin-5.66%
    ROE-12.40%ROIC-8.93%
    Financial Health
    Debt/Equity0.11xInterest CoverageN/A
    Current Ratio4.86xQuick Ratio4.35x
    Trading Statistics
    Beta0.70Avg Volume120.82K
    52-Week High$13.5852-Week Low$9.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$11.60
    SMA 20$11.75
    SMA 50$11.90
    SMA 200$11.25
    EMA 10$11.67
    EMA 20$11.72
    EMA 50$11.70
    EMA 200$11.60

    MACD

    Line: -0.06Signal: -0.07Hist: 0.00

    ADX

    ADX: 12.5+DI: 20.3-DI: 18.1

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down64.0
    PSAR$12.47

    Bollinger Bands

    Upper Band$12.24
    Lower Band$11.25
    %B Position838%(Upper)
    Band Width0.61

    RSI (14-Day)

    Neutral
    53.0

    Momentum Oscillators

    Stoch %K41.1
    Stoch %D31.9
    Williams %R-45.3
    ROC (10d)2.9%
    Momentum0.33
    CCI (20d)-0.6
    MFI (14d)51.1

    Volatility Measures

    ATR (14d)$0.31(2.6%)
    StdDev (20d)0.25
    Hist Vol27.8%(Moderate)

    Volume Flow

    VWAP$11.76
    OBV-8.2M
    AD Line-2.0M
    CMF (20d)-0.233

    Volume Metrics

    Avg Vol (20d)124.1K
    Vol Ratio1.6x(High)
    VWMA (20d)$11.77

    Pivot Points

    R3$12.08
    R2$11.94
    R1$11.80
    Pivot Point$11.66
    S1$11.52
    S2$11.38
    S3$11.24

    Advanced Oscillators

    TSI-6.07
    Ultimate Osc44.7
    KST-29.58

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$76.38M$76.04M$75.10M$89.41M$105.56M$115.73M$119.00M$140.16M$168.56M$174.74M$191.01M$235.87M
    Cost of Revenue$22.99M$24.29M$22.96M$27.25M$28.91M$31.48M$30.78M$34.49M$45.12M$47.45M$49.65M$58.49M
    Gross Profit$53.40M$51.76M$52.14M$62.16M$76.64M$84.25M$88.22M$105.67M$123.44M$127.29M$141.37M$177.38M
    Operating Expenses$57.72M$55.05M$59.94M$66.24M$77.71M$85.51M$87.51M$103.57M$131.31M$119.35M$132.69M$151.87M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$57.72M$55.05M$59.94M$66.24M$77.71M$85.51M$87.51M$103.57M$131.31M$119.35M$132.69M$151.87M
    Operating Income$-4,327,000$-3,295,000$-7,804,000$-4,081,000$-1,066,000$-1,262,000$708,000$2.11M$-7,876,000$7.94M$8.68M$25.51M
    Interest Income$1.35M$1.38M$1.42M$1.43M$1.37M$1.30M$952,000$1.33M$1.30M$1.22M$1.18M$1.03M
    Interest Expense$0$0$0$0$0$0$0$528,000$2.77M$0$0$0
    Income Before Tax$-2,991,000$-1,941,000$-6,383,000$-2,657,000$2.88M$526,000$1.27M$1.58M$-10,650,000$11.59M$9.80M$26.55M
    Income Tax Expense$109,000$181,000$11.74M$-396,000$395,000$1.30M$474,000$449,000$-2,496,000$3.27M$3.77M$3.42M
    Net Income$-3,100,000$-2,122,000$-18,119,000$-2,261,000$2.48M$-772,000$800,000$1.13M$-8,154,000$8.32M$6.04M$23.13M
    EBITDA$-1,042,000$-1,000$-4,494,000$-1,146,000$5.38M$2.31M$3.32M$3.20M$-9,060,000$13.43M$11.81M$28.93M
    EBIT$-4,338,000$-3,320,000$-7,803,000$-4,083,000$1.51M$-775,000$322,000$245,000$-11,946,000$10.36M$8.63M$25.52M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MED

    News

    Medifast Inc (NYSE:MED) Sees Significant Decrease in Short Interest

    Medifast Inc (NYSE:MED) experienced a significant 43.4% decrease in short interest in September, bringing the total to 1.05 million shares...

    MarketBeat•10/15/26•Neutral

    Medifast (NYSE:MED) Stock Bumped Up to Strong-Buy by Zacks Research

    Zacks Research has upgraded Medifast (NYSE:MED) stock from a "hold" to a "strong-buy" rating. Despite this upgrade, overall analyst sentiment remains mixed...

    MarketBeat•10/15/26•Somewhat-Bullish

    Medifast presented Trilivy data and Medifast stock costs EUR 10.16

    Medifast stock traded at EUR 10.16 on October 8, 2026, slightly down from its previous close. The company recently presented new Trilivy metabolic-health data...

    AD HOC NEWS•10/8/26•Neutral

    Medifast stock faces a smaller coach base after Q2 revenue beat

    Medifast reported a Q2 revenue beat of $76.4 million, but its stock is under pressure due to a significant 48.7% year-over-year decrease in its active earning coach base. While coach productivity rose by 41%...

    AD HOC NEWS•10/6/26•Somewhat-Bearish

    Can Medifast's Better Client Retention Support Revenue Stabilization?

    Medifast (MED) is showing signs of business stabilization despite a declining coach base, primarily due to higher coach productivity and improved client retention. While revenues were down year-over-year in Q2 2026...

    TradingView•10/6/26•Somewhat-Bullish

    MED Valuation and Fair Value

    P/E
    -5.1x
    Forward P/E
    12.5x
    P/FCF
    32.9x
    PEG
    1.0x
    P/B
    0.7x
    See GNG's fair value

    MED Profitability: Margins, ROIC and FCF

    Gross margin
    69.2%
    Operating margin
    -5.7%
    Net margin
    -8.1%
    ROIC
    -8.9%
    ROE
    -12.4%
    FCF margin
    1.3%
    FCF yield
    3.0%

    MED Competitors

    CompanyTicker
    Hooker Furniture CorporationHOFT
    1Stdibs.Com IncDIBS
    Tillys IncTLYS
    Traeger IncCOOK
    WW International, IncWW
    Lanvin Group Holdings LimitedLANV
    Brilliant Earth Group IncBRLT
    Plby Group IncPLBY

    Sector: Consumer Cyclical

    MED Bull Case vs Bear Case

    Bull case

    • MED beat EPS estimates in 75.0% of its last 8 reported quarters.

    Bear case

    • MED has a -8.1% net profit margin.
    • MED's quarterly revenue changed -27.6% year over year.

    MED Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    43.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.35
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    MED Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    Frequently Asked Questions About MED

    Does MED pay dividends?

    MEDIFAST INC (MED) has a dividend payment track record. See the MED dividend history page for its current payment status, TTM yield, and recorded payments.

    What is MED's market cap?

    MEDIFAST INC (MED) has a market capitalization of $134.84M with a current stock price of $11.85.

    Related stocks

    Sector: Consumer Cyclical

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In